[Salvage therapy with anti-IL-2 receptor antibodies in high-risk kidney transplant patients].
Carl
S
S
Service d'Urologie, Klinikum der Universität Heidelberg, Allemagne.
Wiesel
M
M
Deiss
J M
JM
Daniel
V
V
Opelz
G
G
Staehler
G
G
D000328:Adult; D000368:Aged; D000911:Antibodies, Monoclonal / Q000627:therapeutic use*; D001379:Azathioprine / Q000627:therapeutic use; D016572:Cyclosporine / Q000627:therapeutic use; D005260:Female; D005938:Glucocorticoids / Q000627:therapeutic use; D006085:Graft Survival; D006801:Humans; D007074:Immunoglobulin G / Q000627:therapeutic use; D007137:Immunoglobulin alpha-Chains / Q000627:therapeutic use; D007165:Immunosuppression Therapy; D007166:Immunosuppressive Agents / Q000627:therapeutic use; D016030:Kidney Transplantation / Q000276:immunology*; D008297:Male; D008775:Methylprednisolone / Q000627:therapeutic use; D008875:Middle Aged; D010865:Pilot Projects; D015375:Receptors, Interleukin-2 / Q000276:immunology*; D012307:Risk Factors; D016879:Salvage Therapy; D013601:T-Lymphocytes / Q000276:immunology
D000911:Antibodies, Monoclonal; D005938:Glucocorticoids; D007074:Immunoglobulin G; D007137:Immunoglobulin alpha-Chains; D007166:Immunosuppressive Agents; D015375:Receptors, Interleukin-2; D016572:Cyclosporine; C079843:inolimomab; D001379:Azathioprine; D008775:Methylprednisolone
Thérapie de sauvetage avec des anticorps anti-récepteurs IL-2 chez des patients transplantés rénaux à haut risque.